Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Exo Therapeutics
Biotech
Romanelli returns to Merck after brief CEO role—Chutes & Ladders
Romanelli rejoins Merck after brief CEO stint. Bayer nabs Frenkl from GSK to guide cancer strategy. Fore has a new leader after ousting its last CEO.
Max Bayer
Apr 22, 2022 9:30am
Novartis-backed Exo says 'XO' to investors for $78M series B
Oct 5, 2021 6:00am
Exo snags $25M to handle 'undruggable' enzymes via exosites
Dec 16, 2020 7:00am
